Letter

“Polypill” to fight cardiovascular disease: Now who's playing God?

BMJ 2003; 327 doi: 10.1136/bmj.327.7418.807-a (Published 2 October 2003)
Cite this as: BMJ 2003;327:807.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Steve Taylor (steve@dox.co.nz), partner,
  2. Angela Konings, partner
  1. Sunset Road Family Doctors, 14/326 Sunset Rd, Mairangi Bay, Auckland 1310, New Zealand

    EDITOR—The implications of Wald and Law's paper are truly monumental.1 Although they are scientifically brilliant and Nobelian in their relevance, they are simultaneously unsettling and alarming.

    The impact of such a low cost initiative on individual and population based health parameters is potentially enormous. But having, at a stroke (to coin a phrase), slashed the risk of cardiovascular disease—what then …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular